Research output per year
Research output per year
Search results
-
2017
Multiplex proximity extension assay of 425 candidate biomarkers in the sera of bladder cancer patients: Correlation with stage and outcome
Ward, D., Gordon, N., Abbotts, B., James, N., Zeegers, M., Cheng, K. & Bryan, R., Mar 2017, In: European Urology Supplements. 16, 3Research output: Contribution to journal › Abstract › peer-review
Open AccessFile183 Downloads (Pure) -
2016
Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer
Kitchen, M., Bryan, R., Emes, R. D., Glossop, J., Luscombe, C., Cheng, K., Zeegers, M., James, N., Devall, A., Mein, C. A. & Gommersall, L., 11 Mar 2016, In: European Urology Supplements. 15, 3, p. e936Research output: Contribution to journal › Abstract › peer-review
-
2013
Use of serum markers in prediction of survival in the trapeze factorial trial evaluating docetaxel with zoledronic acid, strontium-89, or both in castrate-refractory prostate cancer (CRPC) metastatic to bone
Wadhwa, V., Wen, K., Pirrie, S., Pope, A. & James, N., 3 Jun 2013, In: Journal of Clinical Oncology . 31 (supplement), suppl; abstr 5057.Research output: Contribution to journal › Abstract › peer-review
-
2010
Novel uses of coded data in clinical trials
Daunton, A., Liu, D., Collins, S., Pope, A., Barton, D. & James, N., 31 May 2010, In: Journal of Clinical Oncology . 28, no. 15_suppl, p. 6143 6143 p., suppl.6143.Research output: Contribution to journal › Abstract › peer-review
Open Access -
2004
Co-repressor complexes as a novel chemoprevention target for prostate cancer
Campbell, M., Gommersall, L., Khanim, F., Peehl, DM., Doherty, AP. & James, N., 1 Jan 2004.Research output: Contribution to conference (unpublished) › Abstract
-
Targeting SMRT co-repressor complexes as a novel chemoprevention strategy for prostate cancer
Gommersall, L., Marsden, E., Doherty, A., Peehl, DM., James, N. & Campbell, M., 1 Jan 2004.Research output: Contribution to conference (unpublished) › Abstract